UPDATE: BofA Securities Upgrades ResMed (RMD) to Buy; Sees Q1 'Beat'
Tweet Send to a Friend
(Updated - October 20, 2022 9:10 AM EDT)
BofA Securities analyst Lyanne Harrison upgraded ResMed (NYSE: RMD) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Lyanne Harrison upgraded ResMed (NYSE: RMD) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
